Corpus Cavernosum from Men with Vasculogenic Impotence Is Partially Resistant to Adenosine Relaxation due to Endothelial A2B Receptor Dysfunction
暂无分享,去创建一个
P. Correia‐de‐Sá | M. Faria | T. Magalhães-Cardoso | Jose M. Lafuente-de-Carvalho | P. Correia-de-Sá | T. Magalhães-Cardoso
[1] I. Thompson,et al. Erectile dysfunction and subsequent cardiovascular disease. , 2005, JAMA.
[2] A. Gow,et al. Oral Session O04: Intracellular signaling in glia and neurons , 2005 .
[3] J. Huidobro-Toro,et al. A2B adenosine receptor mediates human chorionic vasoconstriction and signals through arachidonic acid cascade. , 2005, American journal of physiology. Heart and circulatory physiology.
[4] P. Correia‐de‐Sá,et al. Dual effects of adenosine on acetylcholine release from myenteric motoneurons are mediated by junctional facilitatory A2A and extrajunctional inhibitory A1 receptors , 2004, British journal of pharmacology.
[5] S. Jamal Mustafa,et al. Relaxation by adenosine and its analogs of potassium-contracted human coronary arteries , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.
[6] J. Kostis,et al. Overview of phosphodiesterase 5 inhibition in erectile dysfunction. , 2003, The American journal of cardiology.
[7] R. Cunha,et al. Ecto‐AMP Deaminase Blunts the ATP‐Derived Adenosine A2A Receptor Facilitation of Acetylcholine Release at Rat Motor Nerve Endings , 2003, The Journal of physiology.
[8] M. Safar,et al. Erectile dysfunction in spontaneously hypertensive rats: pathophysiological mechanisms. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.
[9] W. Martin,et al. Effects of sildenafil on erectile activity in mice lacking neuronal or endothelial nitric oxide synthase , 2002, British journal of pharmacology.
[10] P. Cuevas,et al. Regulation of human penile smooth muscle tone byprostanoid receptors , 2002, British journal of pharmacology.
[11] B. Fredholm,et al. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.
[12] K. Andersson. Pharmacology of penile erection. , 2001, Pharmacological reviews.
[13] H. Inoue,et al. Role of adenosine and P2 receptors in the penile tumescence in anesthetized dogs. , 2001, European journal of pharmacology.
[14] R. Tabrizchi,et al. Pharmacology of adenosine receptors in the vasculature. , 2001, Pharmacology & therapeutics.
[15] C. Müller. Adenosine receptor ligands-recent developments part I. Agonists. , 2000 .
[16] K. Klotz. Adenosine receptors and their ligands , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.
[17] H. Zimmermann. Extracellular metabolism of ATP and other nucleotides , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.
[18] M. Mancini,et al. Functional adenosine receptors in human corpora cavernosa. , 2000, International journal of andrology.
[19] K. Jacobson,et al. Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors. , 2000, Journal of medicinal chemistry.
[20] J. Linden,et al. Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. , 1999, Molecular pharmacology.
[21] T. Cocks,et al. Adenosine mediates relaxation of human small resistance‐like coronary arteries via A2B receptors , 1999, British journal of pharmacology.
[22] N. Gonzalez-Cadavid,et al. Nitric Oxide and the Cyclic GMP System in the Penis. , 1999, Molecular urology.
[23] I. Goldstein,et al. Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction. , 1998, The Journal of urology.
[24] J. Dobson,et al. Adenosine A2a receptors increase arterial endothelial cell nitric oxide. , 1998, The Journal of surgical research.
[25] T. Ogura,et al. Membrane currents underlying the modified electrical activity of guinea‐pig ventricular myocytes exposed to hyperosmotic solution , 1997, The Journal of physiology.
[26] A. Garcı́a-Sacristán,et al. Nitric oxide is involved in the inhibitory neurotransmission and endothelium-dependent relaxations of human small penile arteries. , 1997, Clinical science.
[27] L. Sobrevia,et al. Activation of A2‐purinoceptors by adenosine stimulates L‐arginine transport (system y+) and nitric oxide synthesis in human fetal endothelial cells. , 1997, The Journal of physiology.
[28] M. Watkins,et al. Prostanoid production in rabbit corpus cavernosum: I. regulation by oxygen tension. , 1996, The Journal of urology.
[29] E. Tsai,et al. Adenosine modulation of neurotransmission in human uterine arteries. , 1996, Molecular human reproduction.
[30] F. Ledda,et al. The potent relaxant effect of adenosine in rabbit corpora cavernosa is nitric oxide independent and mediated by A2 receptors. , 1995, Journal of Andrology.
[31] P. Singh,et al. The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A2a selective adenosine receptor antagonist , 1995, British journal of pharmacology.
[32] A. Kosar,et al. Adenosine: a new agent in the diagnosis of impotence. , 1994, International journal of impotence research.
[33] E. Tsai,et al. Adenosine modulation of neurotransmission in penile erection. , 1994, British journal of clinical pharmacology.
[34] T. Iwamoto,et al. Identification of adenosine A2 receptor-cAMP system in human aortic endothelial cells. , 1994, Biochemical and biophysical research communications.
[35] I. Goldstein,et al. Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone. , 1992, The Journal of urology.
[36] G. Broderick,et al. Correlations of purinergic, cholinergic and adrenergic functions in rabbit corporal cavernosal tissue. , 1992, Pharmacology.
[37] J. Rogers,et al. Indomethacin-associated sexual dysfunction. , 1989, The Journal of family practice.
[38] R. Morgan,et al. Prostacyclin synthesis by the corpora cavernosa of the human penis: evidence for muscarinic control and pathological implications. , 1986, Prostaglandins, leukotrienes, and medicine.
[39] J. Daly. Adenosine receptors: targets for future drugs. , 1982, Journal of medicinal chemistry.